Hydroxyurea and Stavudine: Interaction Details
AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Hydroxyurea
Stavudine
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
What happens
Increased risk of severe peripheral neuropathy, increased risk of fatal pancreatitis and hepatotoxicity
Interaction Deep Dive
Concomitant use of hydroxyurea and stavudine should be avoided due to the increased risk of serious and life-threatening adverse events including pancreatitis, hepatotoxicity, and severe peripheral neuropathy421. A case of pancreatitis was reported with the combination of didanosine, stavudine, and nevirapine 3 and cases of fatal hepatic events have been reported in patients treated with the combination of hydroxyurea, didanosine, and stavudine 4. If unavoidable, monitor patients closely for signs and symptoms of pancreatitis and permanently discontinue therapy with hydroxyurea in patients who develop signs and symptoms of pancreatitis 21.
Why it happens (mechanism)
Unknown
Literature reports
2 reports — tap to read
a) Cases of fatal hepatic events have been reported in patients treated with the combination of hydroxyurea, didanosine, and stavudine 421.
b) The addition of hydroxyurea to a medication regimen consisting of didanosine, stavudine, and nevirapine resulted in pancreatitis in a case report. A 26-year-old HIV positive man receiving stavudine 40 mg twice daily, nevirapine 200 mg twice daily, and didanosine 400 mg daily was prescribed hydroxyurea 500 mg twice daily to intensify treatment. The viral load decreased from 81,747 copies/mL to 237 copies/mL, however, the patient began to experience malaise and pain in the upper abdomen. Hydroxyurea was discontinued after 42 days. Three weeks later he was admitted to the hospital with severe pain, vomiting, fever, tenderness of the upper abdomen, and guarding three weeks later. Amylase was 746 units (less than 300) with neutrophil leukocytosis. Computed tomography demonstrated changes consistent with pancreatitis. All medications were discontinued. The author concludes that the addition of hydroxyurea to this patient's treatment regimen may have precipitated didanosine induced pancreatitis 3.
Common questions
Can I take Hydroxyurea and Stavudine together?
Increased risk of severe peripheral neuropathy, increased risk of fatal pancreatitis and hepatotoxicity Always confirm with your pharmacist or prescriber before making any change.
How serious is the Hydroxyurea and Stavudine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "delayed". Effects tend to build up gradually over days to weeks.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Hydroxyurea or Stavudine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (4)
- Product Information: SIKLOS(R) oral tablets, hydroxyurea oral tablets. Medunik USA (per FDA), Rosemont, PA, 2023. DailyMed
- Product Information: DROXIA(R) oral capsules, hydroxyurea oral capsules. H2-Pharma LLC (per FDA), Montgomery, AL, 2023. DailyMed
- Longhurst H & Pinching A: Pancreatitis associated with hydroxyurea in combination with didanosine. BMJ 2001; 322:81.
- Product Information: ZERIT(R) oral capsules, solution, stavudine oral capsules, solution. Bristol-Myers Squibb Company (per FDA), Princeton, NJ, 2017. DailyMed
Keep reading about Hydroxyurea
Keep reading about Stavudine
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist